Detalles de la búsqueda
1.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med
; 385(5): 395-405, 2021 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320285
2.
Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis.
Oncology
; 102(2): 107-113, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699362
3.
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.
Eur J Haematol
; 107(2): 265-274, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33998054
4.
Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis.
BMC Cancer
; 20(1): 1149, 2020 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33238958
5.
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1.
Hematol Oncol
; 38(5): 792-798, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757230
6.
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
Int J Mol Sci
; 21(8)2020 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344757
7.
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
BMC Cancer
; 18(1): 11, 2018 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29298682
8.
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(9): 1745, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934835
9.
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(10): 1825-1839, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29862437
10.
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Support Care Cancer
; 26(4): 1345-1352, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29168033
11.
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Blood
; 126(15): 1762-9, 2015 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26261238
12.
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.
Haematologica
; 102(8): 1361-1367, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28522574
13.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci
; 18(2)2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212292
14.
Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.
Br J Cancer
; 115(10): 1215-1222, 2016 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27764839
15.
Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study.
Support Care Cancer
; 24(2): 667-674, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26123602
16.
Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
Am J Hematol
; 90(4): 288-94, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25545244
17.
Long-term surveillance of locally advanced rectal cancer patients with neoadjuvant chemoradiation and aggressive surgical treatment of recurrent disease: a consecutive single-centre experience.
Int J Colorectal Dis
; 30(12): 1705-14, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26293791
18.
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Lancet Oncol
; 15(8): 862-73, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24928083
19.
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol
; 93(11): 1825-38, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24951123
20.
Functional Precision Medicine Successfully Guides Therapeutic Regimen of 'Cancer of Unknown Primary' Later Classified as Triple-Negative Breast Cancer: A Case Report.
Case Rep Oncol
; 17(1): 490-496, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38545086